| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/19/2008 | US20080145361 Uses of mammalian cytokine; related reagents |
| 06/18/2008 | EP1694825A4 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 06/18/2008 | EP1687349B1 Polyamine polymers |
| 06/17/2008 | CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments |
| 06/17/2008 | CA2251886C An oral pharmaceutical formulation containing ibandronate |
| 06/12/2008 | US20080139509 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/12/2008 | US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis |
| 06/12/2008 | US20080138429 Coated Particles and Pharmaceutical Dosage Forms |
| 06/12/2008 | US20080138410 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138330 Methods and Compositions for Treating Conditions Involving Abnormal Angiogenesis |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/11/2008 | EP1620147A4 Apparatus and methods for repetitive microjet drug delivery |
| 06/11/2008 | EP1599197B1 The use of antimuscarinic drugs |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | CN100393870C Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 06/10/2008 | US7384978 Compounds and methods for delivery of prostacyclin analogs |
| 06/10/2008 | US7384971 Phytochemicals for the treatment of cervical dysplasia |
| 06/10/2008 | US7384970 Inhibitors of cathepsin S |
| 06/10/2008 | US7384962 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | US7384952 1-(3-ethoxybenzyl)-4-[4-[4-[2-(dimethylamino)ethoxy]benzoyl]piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine; small conductance potassium channel (SK channel) blocking activity; gastrointestinal disorders |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384914 Night-time oral insulin therapy |
| 06/05/2008 | US20080131452 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1682085A4 Variable appearance tissue markings |
| 06/04/2008 | CN101193659A Tunstern particl as x-ray contrast |
| 06/04/2008 | CN100391930C 1, 3-propane diol derivatives as bioactive compounds |
| 06/03/2008 | US7381825 Antiinflammatory agents; skin disorders; inflammatory bowel disorders |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | US7381406 Probiotic lactobacillus strains for pets |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125443 nonanalgesic, nonpeptide; for combating ischemic damage and/or effectuating ischemic preconditioning; preservative solution for organ transplants; 4-{(2R,5S)-4-[(R)-(4-Diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl]-2,5-d- imethyl-1-piperazinylmethyl} benzoic acid |
| 05/29/2008 | US20080125388 treating or preventing a condition of excessive cell death by administering a nucleic acid molecule encoding a protein having CPG15-2 biological activity; acts as survival factor by rescuing hippocampal and cortical neurons from cell death; inhibiting activity of CPG15-2 for cancer treatment |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124312 Using topical skin treatment to combat age-related skin pigmentation, skin elasticity, color and smoothness disorders |
| 05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
| 05/28/2008 | EP1691805B1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | CN101186590A Crystalline and pure modafinil, and process of preparing the same |
| 05/28/2008 | CN100390153C Intermediate for producing novel pyrazine derivatives |
| 05/28/2008 | CN100389755C Compositions and methods for mucosal delivery |
| 05/28/2008 | CN100389741C A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 05/28/2008 | CN100389740C A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 05/27/2008 | US7378443 Fatty acid analogues for the treatment of cancer |
| 05/27/2008 | US7378099 Human papillomavirus polypeptides and immunogenic compositions |
| 05/22/2008 | US20080119503 Androgen receptor modulators and methods of use thereof |
| 05/22/2008 | US20080118442 Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation |
| 05/22/2008 | US20080115782 Pressurised metered dose inhalers (mdi) |
| 05/21/2008 | EP1603573B1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 05/21/2008 | DE20221841U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/20/2008 | US7375228 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 05/20/2008 | US7375107 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 05/20/2008 | US7375083 Pharmaceutical compositions for prevention of overdose or abuse |
| 05/20/2008 | US7375076 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein |
| 05/20/2008 | CA2499546C Sustained released delivery of amphetamine salts |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2350801C Hiv replication inhibiting pyrimidines |
| 05/20/2008 | CA2268257C Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 05/15/2008 | US20080114070 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 05/15/2008 | US20080114061 Diphenylethylene compounds and uses thereof |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114047 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens; 2-((4-Amidinobenzofuran-2-yl)methyl)benzofuran-4-carboxamidine; 4,5-Dihydro-2-(2-(2-(5-(4,5-dihydro-1H-imidazol-2-yl)benzofuran-2-yl)ethyl)benzofuran-5-yl)-1H-imidazole |
| 05/15/2008 | US20080114019 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 05/15/2008 | US20080113949 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention |
| 05/15/2008 | US20080113925 Compositions and Methods for Increasing Telomerase Activity |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080112942 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 05/14/2008 | EP1513525B1 Use of mglur5 antagonists for the treatment of gerd |
| 05/14/2008 | CN101177456A Modified transferrin fusion proteins |
| 05/14/2008 | CN101177455A Modified transferrin fusion proteins |
| 05/14/2008 | CN101177415A Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 05/14/2008 | CN101177414A New crystal form of anti-cancer compound ZD1839, preparation method thereof and medical compound containing the crystal form |
| 05/14/2008 | CN100387718C Proteinase K resistant surface protein of neisseria meningitidis |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387594C Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371741 Angiogenesis inhibitor |
| 05/13/2008 | US7371369 Polymeric interpenetrated network carrier and serial polymerization involving a crosslinked polymer network |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/08/2008 | US20080108787 Divinylbenzene-styrene copolymers |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108656 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/08/2008 | US20080108644 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease |
| 05/08/2008 | US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108616 as serine/threonine, fusion, and tyrosine kinase receptors as nerve and fibroblast growth factor; abnormal activation of immune and nervous systems; antiproliferative; lung; 4-(3-Trifluoromethyl-phenylamino)-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-morpholin-4-yl-phenylcarbamoyl)-phenyl]-amide |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080107647 Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation |
| 05/08/2008 | US20080107621 Use Of Il - 6 In Microvascular Complicaitions |